Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Peritoneal Cytokines in Endometriosis
NCT01184144Phase 3Withdrawn
- Sponsor
- University of Wisconsin–Madison
- Start
- Aug 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of pioglitazone in endometriosis (2 arms), sponsored by University of Wisconsin–Madison. Primary endpoint: Peritoneal cytokine levels at 2 weeks. Planned start Aug 2010; status: withdrawn.
02
Drugs
pioglitazone
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT01184144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01184144.